Literature DB >> 25038356

Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial.

Peter MacPherson1, David G Lalloo2, Emily L Webb3, Hendramoorthy Maheswaran4, Augustine T Choko5, Simon D Makombe6, Anthony E Butterworth7, Joep J van Oosterhout8, Nicola Desmond1, Deus Thindwa5, Stephen Bertel Squire2, Richard J Hayes3, Elizabeth L Corbett9.   

Abstract

IMPORTANCE: Self-testing for HIV infection may contribute to early diagnosis of HIV, but without necessarily increasing antiretroviral therapy (ART) initiation.
OBJECTIVE: To investigate whether offering optional home initiation of HIV care after HIV self-testing might increase demand for ART initiation, compared with HIV self-testing accompanied by facility-based services only. DESIGN, SETTING, AND PARTICIPANTS: Cluster randomized trial conducted in Blantyre, Malawi, between January 30 and November 5, 2012, using restricted 1:1 randomization of 14 community health worker catchment areas. Participants were all adult (≥16 years) residents (n = 16,660) who received access to home HIV self-testing through resident volunteers. This was a second-stage randomization of clusters allocated to the HIV self-testing group of a parent trial.
INTERVENTIONS: Clusters were randomly allocated to facility-based care or optional home initiation of HIV care (including 2 weeks of ART if eligible) for participants reporting positive HIV self-test results. MAIN OUTCOMES AND MEASURES: The preplanned primary outcome compared between groups the proportion of all adult residents who initiated ART within the first 6 months of HIV self-testing availability. Secondary outcomes were uptake of HIV self-testing, reporting of positive HIV self-test results, and rates of loss from ART at 6 months.
RESULTS: A significantly greater proportion of adults in the home group initiated ART (181/8194, 2.2%) compared with the facility group (63/8466, 0.7%; risk ratio [RR], 2.94, 95% CI, 2.10-4.12; P < .001). Uptake of HIV self-testing was high in both the home (5287/8194, 64.9%) and facility groups (4433/8466, 52.7%; RR, 1.23; 95% CI, 0.96-1.58; P = .10). Significantly more adults reported positive HIV self-test results in the home group (490/8194 [6.0%] vs the facility group, 278/8466 [3.3%]; RR, 1.86; 95% CI, 1.16-2.97; P = .006). After 6 months, 52 of 181 ART initiators (28.7%) and 15 of 63 ART initiators (23.8%) in the home and facility groups, respectively, were lost from ART (adjusted incidence rate ratio, 1.18; 95% CI, 0.62-2.25, P = .57). CONCLUSIONS AND RELEVANCE: Among Malawian adults offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating ART. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01414413.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25038356      PMCID: PMC4118051          DOI: 10.1001/jama.2014.6493

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.

Authors:  Nancy R Reynolds; Junfeng Sun; Haikady N Nagaraja; Allen L Gifford; Albert W Wu; Margaret A Chesney
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

2.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

3.  The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.

Authors:  Nicolas A Menzies; Andres A Berruti; Richard Berzon; Scott Filler; Robert Ferris; Tedd V Ellerbrock; John M Blandford
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

Review 4.  Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.

Authors:  Darshini Govindasamy; Nathan Ford; Katharina Kranzer
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

Review 5.  Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox
Journal:  PLoS Med       Date:  2011-07-19       Impact factor: 11.069

6.  Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

Authors:  Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

7.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.

Authors:  Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth
Journal:  Lancet       Date:  2009-11-24       Impact factor: 79.321

Review 8.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

9.  Programme costs in the economic evaluation of health interventions.

Authors:  Benjamin Johns; Rob Baltussen; Raymond Hutubessy
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26

Review 10.  Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches.

Authors:  Amitabh B Suthar; Nathan Ford; Pamela J Bachanas; Vincent J Wong; Jay S Rajan; Alex K Saltzman; Olawale Ajose; Ade O Fakoya; Reuben M Granich; Eyerusalem K Negussie; Rachel C Baggaley
Journal:  PLoS Med       Date:  2013-08-13       Impact factor: 11.069

View more
  100 in total

1.  Effectiveness of peer support on care engagement and preventive care intervention utilization among pre-antiretroviral therapy, HIV-infected adults in Rakai, Uganda: a randomized trial.

Authors:  Larry W Chang; Gertrude Nakigozi; Veena G Billioux; Ronald H Gray; David Serwadda; Thomas C Quinn; Maria J Wawer; Robert C Bollinger; Steven J Reynolds
Journal:  AIDS Behav       Date:  2015-10

Review 2.  A Global Review of HIV Self-testing: Themes and Implications.

Authors:  Danielle R Stevens; Caroline J Vrana; Raviv E Dlin; Jeffrey E Korte
Journal:  AIDS Behav       Date:  2018-02

Review 3.  Acceptability of HIV Self-Testing in Sub-Saharan Africa: Scoping Study.

Authors:  Charlene Harichund; M Moshabela
Journal:  AIDS Behav       Date:  2018-02

4.  Verification of HIV Self-Testing Use and Results: A Global Systematic Review.

Authors:  Kadija M Tahlil; Jason J Ong; Nora E Rosenberg; Weiming Tang; Donaldson F Conserve; Susan Nkengasong; Kathryn E Muessig; Juliet Iwelunmor; Oliver Ezechi; Titi Gbaja-Biamila; Sani H Aliyu; Chisom Obiezu-Umeh; Bill Kapogiannis; Joseph D Tucker
Journal:  AIDS Patient Care STDS       Date:  2020-04       Impact factor: 5.078

5.  Effect of Internet-Distributed HIV Self-tests on HIV Diagnosis and Behavioral Outcomes in Men Who Have Sex With Men: A Randomized Clinical Trial.

Authors:  Robin J MacGowan; Pollyanna R Chavez; Craig B Borkowf; S Michele Owen; David W Purcell; Jonathan H Mermin; Patrick S Sullivan
Journal:  JAMA Intern Med       Date:  2020-01-01       Impact factor: 21.873

6.  Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.

Authors:  Ruanne V Barnabas; Heidi van Rooyen; Elioda Tumwesigye; Justin Brantley; Jared M Baeten; Alastair van Heerden; Bosco Turyamureeba; Philip Joseph; Meighan Krows; Katherine K Thomas; Torin T Schaafsma; James P Hughes; Connie Celum
Journal:  Lancet HIV       Date:  2016-03-10       Impact factor: 12.767

Review 7.  Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.

Authors:  Monisha Sharma; Roger Ying; Gillian Tarr; Ruanne Barnabas
Journal:  Nature       Date:  2015-12-03       Impact factor: 49.962

8.  The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America.

Authors:  Pablo F Belaunzarán-Zamudio; Yanink N Caro-Vega; Bryan E Shepherd; Peter F Rebeiro; Brenda E Crabtree-Ramírez; Claudia P Cortes; Beatriz Grinsztejn; Eduardo Gotuzzo; Fernando Mejia; Denis Padgett; Jean W Pape; Vanessa Rouzier; Valdilea Veloso; Sandra Wagner Cardoso; Catherine C McGowan; Juan G Sierra-Madero
Journal:  Am J Epidemiol       Date:  2020-06-01       Impact factor: 4.897

Review 9.  Acceptability and uptake of HIV self-testing in emergency care settings: A systematic review and meta-analysis.

Authors:  Adam R Aluisio; Rachel K Lim; Oliver Y Tang; Janet Sugut; John Kinuthia; Rose Bosire; Kate M Guthrie; David A Katz; Carey Farquhar; Michael J Mello
Journal:  Acad Emerg Med       Date:  2021-07-21       Impact factor: 3.451

10.  Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.

Authors:  Marc d'Elbée; Pitchaya P Indravudh; Lawrence Mwenge; Moses M Kumwenda; Musonda Simwinga; Augustine T Choko; Bernadette Hensen; Melissa Neuman; Jason J Ong; Euphemia L Sibanda; Cheryl C Johnson; Karin Hatzold; Frances M Cowan; Helen Ayles; Elizabeth L Corbett; Fern Terris-Prestholt
Journal:  AIDS       Date:  2018-09-10       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.